SCHEMBL6586680

SCHEMBL6586680

CC(C)CC1c2ccccc2CN1c1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.41
OPRK1 P41145 2/20 0.41
PRCP P42785 1/20 0.38
EED O75530 1/20 0.37
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.33
HTR2A P28223 1/20 0.33
RGS12 O14924 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
RECQL P46063 1/20 0.33
CYP19A1 P11511 2/20 0.33
MTNR1B P49286 1/20 0.32
ACE P12821 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL6589825 0.89 ESR1 (0.37) OPRM1OPRK1LMNAMEN1CYP3A4
Fumaric Acid SCHEMBL6592056 0.89 ESR1 (0.37) OPRM1OPRK1LMNAMEN1CYP3A4
SCHEMBL6587862 0.84 EED (0.40) EEDMAPTNPSR1LMNAHTR2A
SCHEMBL6592097 0.82 EED (0.38) EEDMAPTNPSR1LMNAHTR2A
SCHEMBL6587141 0.76 HTR2A (0.50) OPRM1OPRK1EEDMAPTLMNA
SCHEMBL8519604 0.76 EED (0.34) EEDMAPTNPSR1LMNAHTR2A
SCHEMBL6591541 0.76 TIPARP (0.43) OPRM1PRCPEEDMAPTNPSR1
Maleic Acid SCHEMBL6589717 0.75 SLC6A2 (0.39) MAPTNPSR1LMNAHTR2AKDM4E
Fumaric Acid SCHEMBL6592830 0.75 SLC6A2 (0.39) MAPTNPSR1LMNAHTR2AKDM4E
Fumaric Acid SCHEMBL6589530 0.73 SLC6A2 (0.42) LMNAHTR2AKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP claimed